Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BMRN
#843
BioMarin Pharmaceutical Inc. - Common Stock
59.2
0
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.14%
Monthly Change
+5.56%
6 month change
+5.28%
Year Change
+1.02%
Previous Close
59.1
2
Open
59.2
0
Low
59.2
0
High
59.2
0
Volume
112
Markets
US Stock Market
Healthcare
Biotechnology
BMRN
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
181.83 M
184.03 M
186.53 M
188.68 M
190.78 M
192.32 M
193.28 M
Valuation ratios
Enterprise value
16.37 B
16.75 B
19.13 B
18.83 B
12.19 B
10.72 B
9.35 B
Price to earnings ratio
19.36
-252.43
134.15
112.7
29.74
33.02
43.08
Price to sales ratio
9.03
8.75
9.07
7.77
4.53
3.64
3.62
Price to cash flow ratio
196.9
53.05
108.08
117.96
22.57
14.17
13.36
Price to book ratio
4.09
3.78
4.13
3.79
2.29
1.93
0.48
Enterprise value to EBITDA ratio
239.35
651.93
76.04
71.74
21
21.91
24.03
Profitability ratios
Return on assets %
0.15
-0.01
0.02
0.02
0.06
0.05
0.01
Return on equity %
0.21
-0.02
0.03
0.03
0.08
0.06
0.02
Return on invested capital %
77.99
-6.37
12.57
11.72
29.55
22.46
7.14
Gross margin %
71.82
74.52
76.92
78.72
79.67
77.73
74.55
Operating margin %
-1.98
-4.46
7.14
6.54
16.97
12.71
16.92
EBITDA margin %
3.68
1.39
12
10.85
20.35
15.18
19.06
Net margin %
46.18
-3.47
6.75
6.93
14.96
10.83
13.77
Liquidity ratios
Quick ratio
3.34
2.77
3.15
1.57
3.29
3.5
4.2
Current ratio
4.76
4.21
4.67
2.51
5.33
5.21
5.81
Inventory turnover
0.11
0
0
—
—
0.09
—
Asset turnover
0.35
0.31
0.34
0.37
0.41
0.42
0.09
Solvency ratios
Debt to assets ratio
0.18
0.18
0.17
0.16
0.09
0.08
—
Debt to equity ratio
0.26
0.25
0.24
0.22
0.11
0.1
—
Long term debt to total assets ratio
0.19
0.18
0.17
0.16
0.09
0.08
0.17
Long term debt to total equity ratio
0.27
0.26
0.24
0.22
0.11
0.1
0.23
Per share metrics
Operating cash flow per share
0.45
1.67
0.93
0.83
2.91
4.19
4.48
EBIT per share
-0.19
-0.45
0.79
0.83
2.46
2.07
1.59
EBITDA per share
0.36
0.14
1.33
1.37
2.95
2.48
1.97
Total debt per share
5.62
5.91
5.74
5.67
3.03
3.03
—
Cash per share
5.56
5.54
6.83
5.6
5.78
7.91
11.24
Net current asset value per share
12.22
12.44
14.56
15.43
16.43
20.03
23.3
Tangible book value per share
21.42
23.36
24.36
25.84
28.76
30.84
31.43
Working capital per share
9.65
9.49
11.44
9.29
13.35
16.18
19.28
Book value per share
21.42
23.36
24.36
25.84
28.76
30.84
31.43
News
BridgeBio Stock Taps Rare Disease Trends and New Diagnosis Growth
Is BBIO Stock a Buy Now or Too Expensive for the Risk Ahead
BridgeBio Stock Outlook Hinges on Attruby & New Drug Catalysts
Ascendis Pharma Stock: Behind The Stock Surge (NASDAQ:ASND)
Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
ABCELLERA BIOLG (ABCL) Surges 7.1%: Is This an Indication of Further Gains?
BioMarin (BMRN) Up 0.2% Since Last Earnings Report: Can It Continue?
JPMorgan says large-cap biotech is back as profits and pipelines fuel upside
BioMarin's Voxzogo Meets Goal in Late-Stage Study for Hypochondroplasia
BMRN Stock Down on Mixed Results From Rare Disease Therapy Study
BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised
BioMarin Pharmaceutical Inc. (BMRN) Q1 2026 Earnings Call Transcript